HIV Physicians and Chronic Opioid Therapy: It's Time to Raise the Bar.
Analgesics, Opioid
/ administration & dosage
Chronic Pain
/ drug therapy
Drug Prescriptions
Female
HIV Infections
/ complications
Health Knowledge, Attitudes, Practice
Humans
Interviews as Topic
Male
Middle Aged
Physician-Patient Relations
Physicians
/ psychology
Practice Patterns, Physicians'
Qualitative Research
Substance-Related Disorders
HIV
Opioids
Pain
Prescribing
Safety
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
pubmed:
7
12
2018
medline:
19
6
2019
entrez:
7
12
2018
Statut:
ppublish
Résumé
Clinical practice that utilizes chronic opioid therapy has been recognized as one major cause of the opioid crisis. Among patients living with HIV, the risks associated with chronic opioid therapy may be complicated by factors such as co-occurring mental health diagnoses, substance use, and economic marginalization. Improving opioid prescribing practices in HIV clinics requires attention to these and other characteristics common to HIV care. In the context of a randomized controlled trial testing an intervention to improve opioid prescribing practices in HIV outpatient clinics, we interviewed physicians about their perspectives on chronic opioid therapy. Overwhelmingly, physicians voiced ambivalence about their own knowledge and comfort with prescription opioids. They raised concerns about the impact of opioid prescribing on patient-provider relationships and the increasing workload associated with prescribing and monitoring patients. In this report, we explore these concerns and propose several strategies for improving clinical care in which chronic opioid therapy is addressed.
Identifiants
pubmed: 30519904
doi: 10.1007/s10461-018-2356-2
pii: 10.1007/s10461-018-2356-2
pmc: PMC6610859
mid: NIHMS1524887
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1057-1061Subventions
Organisme : NIDA NIH HHS
ID : R01 DA037768
Pays : United States
Organisme : National Institute on Drug Abuse (US)
ID : R01DA037768
Références
Int J Drug Policy. 2017 Aug;46:107-111
pubmed: 28735776
Am J Med. 2014 Mar;127(3):183-7
pubmed: 24384059
MMWR Surveill Summ. 2014 Dec 19;63(14):1-39
pubmed: 25522191
JAMA. 2017 Jan 24;317(4):361-362
pubmed: 28118458
Subst Abus. 2016;37(1):148-53
pubmed: 26860130
J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S91-7
pubmed: 21317601
J Pain Symptom Manage. 2011 Dec;42(6):893-902
pubmed: 21802896
Pain Pract. 2014 Mar;14(3):207-16
pubmed: 23551857
Pain Med. 2015 Apr;16(4):706-14
pubmed: 25645646
JAMA Intern Med. 2017 Sep 1;177(9):1272
pubmed: 28715556
Clin Infect Dis. 2019 Jan 7;68(2):291-297
pubmed: 29860411
Clin Infect Dis. 2017 Oct 30;65(10):e1-e37
pubmed: 29020263
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
Int J Drug Policy. 2014 Mar;25(2):257-66
pubmed: 24238956
Mayo Clin Proc. 2018 Mar;93(3):344-350
pubmed: 29502564
JAMA Intern Med. 2017 Sep 1;177(9):1265-1272
pubmed: 28715535
Pain Med. 2015 Oct;16(10):1870-81
pubmed: 26119642
Mil Med. 2016 Mar;181(3):227-35
pubmed: 26926747
Clin Neuropsychol. 2015;29(2):232-54
pubmed: 25871409
J Pain. 2012 Jul;13(7):704-13
pubmed: 22748803